Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein-centric drug development and functional glycomics enrich biopharmaceuticals pipeline

29.04.2004


Technical Insights biotechnology industry impact service



Researchers are beginning to see the potential for breakthrough in healthcare through glycomics, which studies carbohydrates, proteins and their interactions. In fact, these carbohydrates are moving beyond their regular roles as sugar storage bins. Carbohydrate-binding proteins are becoming extremely useful in curing various illnesses.

"The rapid evolution of glycomics as a natural extension of proteomics provides a better understanding of glycoproteins, glycosylation process, and its role in the protein function," explains Frost & Sullivan Industry Analyst Giridhar Rao. "This in turn facilitates the development of novel biodrugs."


The rapid progress of glycomics in the biopharmaceutical industry is evident from the existence of approximately half a dozen drugs, in which manipulation of carbohydrates and proteins provides advanced drug properties. For example, Epogen – a glycotherapeutic drug – contains two additional carbohydrate groups that can extend circulatory half-life and magnify efficiencies.

Active research on glycosyltransferases to understand the role of carbohydrate interactions in a cancerous cell is also likely to provide further opportunities for application of glycomics. One such prospect lies in the development of protein serum-based cancer diagnostics.

In fact, glycoprotein therapeutics is the fastest growing segment in the biopharmaceuticals industry with an annual growth rate of 24 percent, which is expected to accelerate further. However, maintaining adequate manufacturing capacity is a critical challenge.

"With around 100 protein-based drugs that are in late-stages of human clinical trials, few are likely to hit the market in the coming years," says Rao. "Hence, raising the demand for production capacity at least by four times more than the existing capacity. This may be essential to maintain the demand-supply equilibrium."

This creates an urgent need for alternate manufacturing media such as transgenic plants and animals, besides the mammalian and microbial and fungal cell culture systems.

Fungal cell lines provide considerable time and cost benefits over mammalian cell lines. For instance, the latter proves to be a lengthy process and may alter the properties of the final therapeutic glycoprotein.

Conversely, fungal cell lines such as engineered yeast expression systems for production of humanly glycosylated protein provide for faster fermentation and a higher product yield.

Industrial bioprocessing also holds immense potential for biotechnology. The development of a sophisticated microbioreactor for bacterial cell culture could speed up the bioprocessing mechanism.

A 5- to 50-microliter microbioreactor provides significant advantages over traditional chemical processes, such as lower temperature, pressure, and almost neutral pH requirements. Also, mass production with lesser power consumption is viable since the raw materials are renewable living cells.

Nano-biotechnology proves to be another potential growth area, where the endless possibilities of ’doing big with small’ exist. This has sparked an explosion of research and has influenced the commercialization of many nano drug delivery technologies.

For instance, the uniquely small-sized carbon buckyballs and nanotubes are proving to be successful nano-carriers that are small enough to navigate within the body. Thereby, they could serve as effective carriers of active ingredients for cancer treatment. However, dealing with the toxicity of trace nanoparticles that could be left behind in the body, is a major concern.

Another promising technique is nano-sized dendrimers that escape the blood stream through vascular pores, and selectively target and treat tumor cells. Dendrimer-based drugs coupled with additional agents provide high-end tumor images and hence could revolutionize cancer treatment.

Julia Paulson | EurekAlert!
Further information:
http://www.frost.com
http://www.technicalinsights.frost.com

More articles from Life Sciences:

nachricht Monitoring biodiversity with sound: how machines can enrich our knowledge
18.06.2019 | Georg-August-Universität Göttingen

nachricht Uncovering hidden protein structures
18.06.2019 | Universität Konstanz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The hidden structure of the periodic system

The well-known representation of chemical elements is just one example of how objects can be arranged and classified

The periodic table of elements that most chemistry books depict is only one special case. This tabular overview of the chemical elements, which goes back to...

Im Focus: MPSD team discovers light-induced ferroelectricity in strontium titanate

Light can be used not only to measure materials’ properties, but also to change them. Especially interesting are those cases in which the function of a material can be modified, such as its ability to conduct electricity or to store information in its magnetic state. A team led by Andrea Cavalleri from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg used terahertz frequency light pulses to transform a non-ferroelectric material into a ferroelectric one.

Ferroelectricity is a state in which the constituent lattice “looks” in one specific direction, forming a macroscopic electrical polarisation. The ability to...

Im Focus: Determining the Earth’s gravity field more accurately than ever before

Researchers at TU Graz calculate the most accurate gravity field determination of the Earth using 1.16 billion satellite measurements. This yields valuable knowledge for climate research.

The Earth’s gravity fluctuates from place to place. Geodesists use this phenomenon to observe geodynamic and climatological processes. Using...

Im Focus: Tube anemone has the largest animal mitochondrial genome ever sequenced

Discovery by Brazilian and US researchers could change the classification of two species, which appear more akin to jellyfish than was thought.

The tube anemone Isarachnanthus nocturnus is only 15 cm long but has the largest mitochondrial genome of any animal sequenced to date, with 80,923 base pairs....

Im Focus: Tiny light box opens new doors into the nanoworld

Researchers at Chalmers University of Technology, Sweden, have discovered a completely new way of capturing, amplifying and linking light to matter at the nanolevel. Using a tiny box, built from stacked atomically thin material, they have succeeded in creating a type of feedback loop in which light and matter become one. The discovery, which was recently published in Nature Nanotechnology, opens up new possibilities in the world of nanophotonics.

Photonics is concerned with various means of using light. Fibre-optic communication is an example of photonics, as is the technology behind photodetectors and...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

Uncovering hidden protein structures

18.06.2019 | Life Sciences

Monitoring biodiversity with sound: how machines can enrich our knowledge

18.06.2019 | Life Sciences

Schizophrenia: Adolescence is the game-changer

18.06.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>